UBS analysts, who raised their price target on Accor's stock to 36.50 euros from 29.10 euros, say they have increased their RevPar growth forecast to 3.0 percent from 2.0 percent for 2014 and to 3.0 percent from 1.3 percent for 2015. The …
On the other hand, high stock valuations may lead to mergers between participants ... expand their portfolios through targeted acquisitions of smaller regional chains. …
One stock that might be an intriguing choice for investors right now is Acorda Therapeutics, Inc. (ACOR). This is because this security in the Medical – Biomedical/Genetics space is seeing solid earnings estimate revision activity, and is in …
Baird downgrades Acorda Therapeutics (Nasdaq: ACOR) to Neutral, retains $32 price target ... We still very much like the story and would look to reengage should the stock retreat back to the mid-$20s." To see all the …
Acorda Therapeutics, Inc. ACOR reported adjusted earnings of 6 cents per share in the second quarter of 2017 (including the impact of stock-based compensation expenses), compared with a loss of 41 cents per share in the year-ago …
Mantra floated at $1.80. Accor is offering $3.96 per share including a potential special dividend. The offer price is lower than Mantra's peak of $5 a share in December 2015 before concerns about Airbnb drove down the stock but investors in the …
with Accor rumoured to be in exclusive due diligence to purchase the hotel group. But this morning Mantra released a statement to the stock exchange regarding “recent press speculation”, confirming the rumours. It stated, “Mantra …
Mantra Group is the best-performing stock on the ASX today, after it received a $1.2 billion takeover offer from Paris-based Accor Hotels. The share price of Australia's second largest hotel group jumped 17.5 per cent to $3.80 (at 12:55pm …
Among the companies with shares expected to trade actively in Friday's session are Foot Locker Inc. (FL), Deere & Co. (DE) and Acorda Therapeutics Inc (ACOR). Foot Locker Inc ... but the off-price retailer's stock slid on lackluster sales …